Conversely, higher concentrations of selenoprotein P (PSELENOP) correlate with a reduced risk of CRC, with particularly significant effects observed in women.[87] Therefore, regulating selenium intake and optimizing selenium status could potentially exert a positive impact on the prevention and treatment of CRC. The gene discussed is SELENOP; the disease is colorectal carcinoma.